|
Biochemical parameters at genotyping. Mean and 95% confidence intervals of all readings taken within 2 years prior to enrolment in study |
||||||
| L162V |
||||||
| L/L |
L/V |
V/V |
||||
|
|
||||||
| BMI |
30.5 |
30.2–30.7 |
30.7 |
30.0–31.4 |
28.9 |
26.0–31.9 |
| SBP mmHg |
142.5 |
141.7-141.3 |
141.3 |
139.3–143.3 |
134.9 |
126.7–143.1 |
| DBP mmHg |
79.5 |
79.1–79.8 |
79.7 |
78.6–80.7 |
77.3 |
73.1–81.5 |
| Cholrat† mmol/L |
4.5 |
4.4–4.6 |
4.8 |
4.5–5.0 |
4.3 |
3.3–5.3 |
| Chol mmol/L |
5.2 |
5.2–5.3 |
5.3 |
5.1–5.4 |
5.3 |
4.8–5.8 |
| Trigs mmol/L |
2.7 |
2.6–2.8 |
2.8 |
2.6–3.1 |
2.4 |
1.3–3.5 |
| HDL mmol/L |
1.22 |
1.20–1.24 |
1.23 |
1.20–1.28 |
1.31 |
1.13–1.50 |
| LDL mmol/L |
2.89 |
2.84–2.92 |
2.89 |
2.78–3.00 |
2.92 |
2.42–3.41 |
| G2528C |
||||||
| G/G |
G/C |
C/C |
||||
|
|
||||||
| BMI |
30.5 |
30.2–30.8 |
30.4 |
29.9–30.8 |
31.40 |
30.1–32.7 |
| SBP mmHg |
142.5 |
141.7–143.4 |
142 |
140.7–143.3 |
140.2 |
135.5–143.9 |
| DBP mmHg |
79.5 |
79.0–79.9 |
79.7 |
79.0–80.3 |
78.2 |
76.3–80.1 |
| Cholrat† mmol/L |
4.49 |
4.37–4.60 |
4.74 |
4.57–4.91 |
4.51 |
4.03–4.98 |
| Chol mmol/L |
5.20 |
5.15–5.25 |
5.26 |
5.18–5.34 |
5.56 |
5.33–5.79* |
| Trigs mmol/L |
2.73 |
2.62–2.83 |
2.75 |
2.59–2.91 |
2.65 |
2.18–3.12 |
| HDL mmol/L |
1.22 |
1.20–1.24 |
1.23 |
1.20–1.25 |
1.25 |
1.17–1.34 |
| LDL mmol/L |
2.88 |
2.83–2.92 |
2.88 |
2.81–2.95 |
3.22 |
3.01–3.44* |
|
*P < 0.05 ANOVA co-dominant model † Cholrat = Total cholesterol/HDL Ratio | ||||||
Doney et al. Nuclear Receptor 2005 3:4 doi:10.1186/1478-1336-3-4 |
||||||